Gene · 3161
Papers2,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD168+ macrophages promote hepatocellular carcinoma tumor stemness and progression through TOP2A/β-catenin/YAP1 axis. | iScience | 2023 | 37275516 | PubTator, text mining | PubMed |
| The relationship between the Hippo signaling pathway and bone metastasis of breast cancer. | Front Oncol | 2023 | 37256184 | PubTator, text mining | PubMed |
| New Challenges and Prospective Applications of Three-Dimensional Bioactive Polymeric Hydrogels in Oral and Craniofacial Tissue Engineering: A Narrative Review. | Pharmaceuticals (Basel) | 2023 | 37242485 | PubTator, text mining | PubMed |
| Targeted Drug Administration onto Cancer Cells Using Hyaluronic Acid-Quercetin-Conjugated Silver Nanoparticles. | Molecules | 2023 | 37241888 | PubTator, text mining | PubMed |
| Role of Extracellular Vesicles in Liver Diseases. | Life (Basel) | 2023 | 37240762 | PubTator, text mining | PubMed |
| Skin aging from mechanisms to interventions: focusing on dermal aging. | Front Physiol | 2023 | 37234413 | PubTator, text mining | PubMed |
| Hmmr Acts as a Key Regulator in the ADSCs Proliferation and Mitosis. | Stem Cell Rev Rep | 2023 | 37222947 | PubTator, text mining | PubMed |
| Identification of fatty acid-related subtypes, the establishment of a prognostic signature, and immune infiltration characteristics in lung adenocarcinoma. | Aging (Albany NY) | 2023 | 37199651 | PubTator, text mining | PubMed |
| An Integrative Multi-Omics Analysis of The Molecular Links between Aging and Aggressiveness in Thyroid Cancers. | Aging Dis | 2023 | 37191407 | PubTator, text mining | PubMed |
| Exploring Monocytes-Macrophages in Immune Microenvironment of Glioblastoma for the Design of Novel Therapeutic Strategies. | Brain Sci | 2023 | 37190507 | PubTator, text mining | PubMed |
| The Enhanced Expression of ZWILCH Predicts Poor Survival of Adrenocortical Carcinoma Patients. | Biomedicines | 2023 | 37189849 | PubTator, text mining | PubMed |
| Intra-Articular Hyaluronic Acid in Osteoarthritis and Tendinopathies: Molecular and Clinical Approaches. | Biomedicines | 2023 | 37189679 | PubTator, text mining | PubMed |
| Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients. | J Pathol | 2023 | 37186300 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts and Extracellular Matrix: Therapeutical Strategies for Modulating the Cholangiocarcinoma Microenvironment. | Curr Oncol | 2023 | 37185432 | PubTator, text mining | PubMed |
| A class of peptides designed to replicate and enhance the Receptor for Hyaluronic Acid Mediated Motility binding domain. | Acta Biomater | 2023 | 37178990 | PubTator, text mining | PubMed |
| The interplay of cells, polymers, and vascularization in three-dimensional lung models and their applications in COVID-19 research and therapy. | Stem Cell Res Ther | 2023 | 37118810 | PubTator, text mining | PubMed |
| Exposure to dietary fatty acids oleic and palmitic acid alters structure and mechanotransduction of intestinal cells in vitro. | Arch Toxicol | 2023 | 37117602 | PubTator, text mining | PubMed |
| Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application. | Molecules | 2023 | 37110771 | PubTator, text mining | PubMed |
| Altered Glycosylation in Progression and Management of Bladder Cancer. | Molecules | 2023 | 37110670 | PubTator, text mining | PubMed |
| Hyaluronan and Reactive Oxygen Species Signaling-Novel Cues from the Matrix? | Antioxidants (Basel) | 2023 | 37107200 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3161/papers?page=14